US FDA's new patient affairs office will not be an actual "office" in the official sense of the word, but will remain a group working to help patients and advocates find their way around the agency.
In part because of the bureaucratic moves that would be necessary to make such a change, the agency is instead creating a patient affairs group, said Principal Deputy Commissioner Rachel...